FIELD: medicine.
SUBSTANCE: peptide is described by general formula I: X1-X2-X3-X4-X5 (I) where XI represents Q or V; X2 represents P; X3 represents G or (β-A); X4 represents R, or X4 represents K with X1-Q or with X1-V and X3-(p-A); X5 represents G, where G is glycine, (β-A) is β-alanine, P is proline, V is valine, Q is glutamine, K is lysine, R is arginine.
EFFECT: invention presents extended range of effective therapeutic agents involved in liver regeneration.
4 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE HAVING GROWTH-STIMULATING FACTOR OF HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR | 2008 |
|
RU2385875C2 |
| OLIGOPEPTIDE HAVING TRANSFORMATION GROWTH FACTOR (TGF-β) AND ONCOSTATIN M (OSM) TOWARDS FIBROBLAST PROLIFERATION | 2008 |
|
RU2385874C2 |
| OLIGOPEPTIDE HAVING CARTILAGE-DERIVED MORPHOGENETIC PROTEIN (CDMP-1) ACTIVITY ON CHONDROCYTE PROLIFERATION | 2009 |
|
RU2408603C1 |
| OLIGOPEPTIDE HAVING ACIDIC (aFGF) AND TRANSFORMING (TGF-β) GROWTH FACTOR ACTIVITY TOWARDS STIMULATION OF COLLAGEN BIOSYNTHESIS | 2008 |
|
RU2385873C2 |
| OLIGOPEPTIDE WITH ACTIVITY OF VASCULAR ENDOTHELIUM GROWTH FACTOR (VEGF) WITH RESPECT TO ANGIOGENESIS STIMULATION | 2008 |
|
RU2375373C1 |
| THYROID GLAND FOLLICULAR CELL PROLIFERATION STIMULATING OLIGOPEPTIDE | 2008 |
|
RU2393166C1 |
| OLIGOPEPTIDE WITH STEM CELL FACTOR CSF ACTIVITY TOWARDS THYMOCYTE DIFFERENTIATION | 2008 |
|
RU2374262C1 |
| OLIGOPEPTIDE HAVING NEUREGULIN-1 ACTIVITY ON CARDIOMYOCYTE PROLIFERATION | 2010 |
|
RU2439078C1 |
| MONOCLONAL ANTIBODIES TO HEPATOCYTE GROWTH FACTOR | 2004 |
|
RU2361879C2 |
| HUMANISED MONOCLONAL ANTIBODIES TO HEPATOCYTE GROWTH FACTOR | 2007 |
|
RU2461570C2 |
